Chen RJ, Jinn TR, Chen YC, Chung TY, Yang WH, Tzen JT. Active ingredients in Chinese medicines promoting blood circulation as Na+/K+-ATPase inhibitors. Acta Pharmacol Sin 2011;32:141–151.

Chen CF, Chiou WF, Zhang JT. Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium. Acta Pharmacol Sin 2008;29:1103–1108.

Park CS, Yoo MH, Noh KH, Oh DK. Biotransformation of ginsenosides by hydrolyzing the sugar moieties of ginsenosides using microbial glycosidases. Appl Microbiol Biotechnol 2010;87:9–19.

Yeh GY, Davis RB, Phillips RS. Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol 2006;98:673–680.

Pharand C, Ackman ML, Jackevicius CA, Paradiso-Hardy FL, Pearson GJ. Use of OTC and herbal products in patients with cardiovascular disease. Ann Pharmacother 2003;37:899–904.

Harnack LJ, Rydell SA, Stang J. Prevalence of use of herbal products by adults in the Minneapolis/St Paul, Minn, metropolitan area. Mayo Clin Proc 2001;76:688–694.

Shim YH, Park CD, Kim DH, Cho JH, Cho MH, Kim HJ. Identification of Panax species in the herbal medicine preparations using gradient PCR method. Biol Pharm Bull 2005;28:671–676.

Xie G, Plumb R, Su M, Xu Z, Zhao A, Qiu M, et al. Ultraperformance LC/TOF MS analysis of medicinal Panax herbs for metabolomic research. J Sep Sci 2008;31:1015–1026.

Leung KS, Chan K, Bensoussan A, Munroe MJ. Application of atmospheric pressure chemical ionisation mass spectrometry in the identification and differentiation of Panax species. Phytochem Anal 2007;18:146–150.

Qi LW, Wang CZ, Yuan CS. Isolation and analysis of ginseng: advances and challenges. Nat Prod Rep 2011;28:467–495.

Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk P, Leung HW, et al. Modulating angiogenesis: the yin and the yang in ginseng. Circulation 2004;110:1219–1225.

Nah SY, Kim DH, Rhim H. Ginsenosides: are any of them candidates for drugs acting on the central nervous system? CNS Drug Rev 2007;13:381–404.

Zhang C, Yu H, Bao Y, An L, Jin F. Purification and characterization of ginsenoside-β-glucosidase from ginseng. Chem Pharm Bull (Tokyo) 2001;49:795–798.

Yu H, Gong J, Zhang C, Jin F. Pur i f icat ion and characterization of ginsenoside-α-L-rhamnosidase. Chem Pharm Bull (Tokyo) 2002;50:175–178.

Yan Q, Zhou W, Li X, Feng M, Zhou P. Purification method improvement and characterization of a novel ginsenosidehydrolyzing beta-glucosidase from Paecilomyces Bainier sp. 229. Biosci Biotechnol Biochem 2008;72:352–359.

Wang CZ, Aung HH, Ni M, Wu JA, Tong R, Wicks S, et al. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med 2007;73:669–674.

Zhang SL, Chen YJ, Cui CB, He GX, Xu SX, Pei YP, et al. A new minor saponin from the leaves of Panax ginseng C. A. Meyer. Acta Pharm Sin 1989;24:877–879.

Yuan J, Guo W, Yang B, Liu P, Wang Q, Yuan H. 116 cases of coronary angina pectoris treated with powder composed of Radix Ginseng, Radix Notoginseng and Succinum. J Tradit Chin Med 1997;17:14–17.

Maffei Facino R, Carini M, Aldini G, Berti F, Rossoni G. Panax ginseng administration in the rat prevents myocardial ischemia-reperfusion damage induced by hyperbaric oxygen: evidence for an antioxidant intervention. Planta Med 1999;65:614–619.

Gillis CN. Panax ginseng pharmacology: a nitric oxide link? Biochem Pharmacol 1997;54:1–8.

Zhang D, Yasuda T, Yu Y, Zheng P, Kawabata T, Ma Y, et al. Ginseng extract scavenges hydroxyl radical and protects unsaturated fatty acids from decomposition caused by iron-mediated lipid peroxidation. Free Radic Biol Med 1996;20:145–150.

Deng HL, Zhang JT. Anti-lipid peroxilative effect of ginsenoside Rb1 and Rg1. Chin Med J 1991;104:395–398.

Kim TH, Lee SM. The effects of ginseng total saponin, panaxadiol and panaxatriol on ischemia/reperfusion injury in isolated rat heart. Food Chem Toxicol 2010;48:1516–1520.

Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol Physiol 1996;23:728–732.

Yi XQ, Li T, Wang JR, Wong VK, Luo P, Wong IY, et al. Total ginsenosides increase coronary perfusion flow in isolated rat hearts through activation of PI3K/Akt-eNOS signaling. Phytomedicine 2010;17:1006–1015.

Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg 2005;41:861–868.

Chai H, Zhou W, Lin P, Lumsden A, Yao Q, Chen C. Ginsenosides block HIV protease inhibitor ritonavir-induced vascular dysfunction of porcine coronary arteries. Am J Physiol Heart Circ Physiol 2005;288:H2965–H2971.

Xie JT, Shao ZH, Vanden Hoek TL, Chang WT, Li J, Mehendale S, et al. Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur J Pharmacol 2006;532:201–207.

Zhu D, Wu L, Li CR, Wang XW, Ma YJ, Zhong ZY, et al. Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis. J Cell Biochem 2009;108:117–124.

You JS, Huang HF, Chang YL. Panax ginseng reduces adriamycin-induced heart failure in rats. Phytother Res 2005;19:1018–1022.

Guo J, Gan XT, Haist JV, Rajapurohitam V, Zeidan A, Faruq NS, et al. Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation. Circ Heart Fail 2011;4:79–88.

Qin N, Gong QH, Wei LW, Wu Q, Huang XN. Total ginsenosides inhibit the right ventricular hypertrophy induced by monocrotaline in rats. Biol Pharm Bull 2008;31:1530–1535.

Jiang QS, Huang XN, Dai ZK, Yang GZ, Zhou QX, Shi JS, et al. Inhibitory effect of ginsenoside Rb1 on cardiac hypertrophy induced by monocrotaline in rat. J Ethnopharmacol 2007;111:567–572.

Jiang QS, Huang XN, Yang GZ, Jiang XY, Zhou QX. Inhibitory effect of ginsenoside Rb1 on calcineurin signal pathway in cardiomyocyte hypertrophy induced by prostaglandin F2α. Acta Pharmacol Sin 2007;28:1149–1154.

Zhao H, LU D, Zhang W, Dong W, Feng J, Xiang Z, et al. Ginsenoside-Rb1 attenuates dilated cardiomyopathy in cTnT(R141W) transgenic mouse. J Pharmacol Sci 2010;112:214–222.

Deng J, LU XT, Wu Q, Huang XN. Ginsenoside Rg1 inhibits rat left ventricular hypertrophy induced by abdominal aorta coarctation: involvement of calcineurin and mitogenactivated protein kinase signalings. Eur J Pharmacol 2009;608(1–3):42–47.

Deng J, Wang YW, Chen WM, Wu Q, Huang XN. Role of nitric oxide in ginsenoside Rg1-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats. Biol Pharm Bull 2010;33:631–635.

Toh HT. Improved isolated heart contractility and mitochondrial oxidation after chronic treatment with Panax ginseng in rats. Am J Chin Med 1994;22:275–284.

Li XT, Chen R, Jin LM, Chen HY. Regulation on energy metabolism and protection on mitochondria of Panax ginseng polysaccharide. Am J Chin Med 2009;37:1139–1152.

Kong HL, Wang JP, Li ZQ, Zhao SM, Dong J, Zhang WW. Anti-hypoxic effect of ginsenoside Rb1 on neonatal rat cardiomyocytes is mediated through the specific activation of glucose transporter-4 ex vivo. Acta Pharmacol Sin 2009;30:396–403.

Wang YG, Zima AV, Ji X, Pabbidi R, Blatter LA, Lipsius SL. Ginsenoside Re suppresses electromechanical alternans in cat and human cardiomyocytes. Am J Physiol Heart Circ Physiol 2008;295:H851–H859.

Scott GI, Colligan PB, Ren BH, Ren J. Ginsenosides Rb1 and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide. Br J Pharmacol 2001;134:1159–1165.

Jin ZQ. The action of ginsenoside Re on inotropy and chronotropy of isolated atria prepared from guinea pigs. Planta Med 1996;62:314–316.

Bai CX, Sunami A, Namiki T, Sawanobori T, Furukawa T. Electrophysiological effects of ginseng and ginsenoside Re in guinea pig ventricular myocytes. Eur J Pharmacol 2003;476:35–44.

Bai CX, Takahashi K, Masumiya H, Sawanobori T, Furukawa T. Nitric oxide-dependent modulation of the delayed rectifier K+ current and the L-type Ca2+ current by ginsenoside Re, an ingredient of Panax ginseng, in guineapig cardiomyocytes. Br J Pharmacol 2004;142:567–575.

Furukawa T, Bai CX, Kaihara A, Ozaki E, Kawano T, Nakaya Y, et al. Ginsenoside Re, a main phytosterol of Panax ginseng, activates cardiac potassium channels via a nongenomic pathway of sex hormones. Mol Pharmacol 2006;70:1916–1924.

Choi SH, Shin TJ, Lee BH, Chu DH, Choe H, Pyo MK, et al. Ginsenoside Rg3 activates human KCNQ1 K+ channel currents through interacting with the K318 and V319 residues: a role of KCNE1 subunit. Eur J Pharmacol 2010;637:138–147.

Jeong SM, Lee JH, Kim JH, Lee BH, Yoon IS, Kim DH, et al. Stereospecificity of ginsenoside Rg3 action on ion channels. Mol Cells 2004;18:383–389.

Lee JH, Lee BH, Choi SH, Yoon IS, Pyo MK, Shin TJ, et al. Ginsenoside Rg3 inhibits human Kv1.4 channel currents by interacting with the Lys531 residue. Mol Pharmacol 2008;73:619–626.

Lee JH, Choi SH, Lee BH, Shin TJ, Pyo MK, Hwang SH, et al. The effects of ginsenoside Rg3 on human Kv1.4 channel currents without the N-terminal rapid inactivation domain. Biol Pharm Bull 2009;32:614–618.

Kim CS, Son SJ, Kim HS, Kim YD, Lee KS, Jeon BH, et al. Modulating effect of ginseng saponins on heterologously expressed HERG currents in Xenopus oocytes. Acta Pharmacol Sin 2005;26:551–558.

Jin ZQ, Liu CM. Ef fect of ginsenoside Re on the electrophysiological activity of the heart. Planta Med 1994;60:192–193.

Lee JH, Jeong SM, Kim JH, Lee BH, Yoon IS, Choi SH, et al. Effects of ginsenosides and their metabolites on voltagedependent Ca2+ channel subtypes. Mol Cells 2006;21:52–62.

Choi SH, Lee JH, Pyo MK, Lee BH, Shin TJ, Hwang SH, et al. Mutations Leu427, Asn428, and Leu431 residues within transmembrane domain-I-segment 6 attenuate ginsenosidemediated L-type Ca2+ channel current inhibitions. Biol Pharm Bull 2009;32:1224–1230.

Luo J, Min S, Wei K, Cao J. Ion channel mechanism and ingredient bases of Shenfu Decoction’s cardiac electrophysiological effects. J Ethnopharmacol 2008;117:439–445.

Xiang YZ, Shang HC, Gao XM, Zhang BL. A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials. Phytother Res 2008;22:851–858.

Fu Y, Ji LL. Chronic ginseng consumption attenuates ageassociated oxidative stress in rats. J Nutr 2003;133:3603–3609.

Shao ZH, Xie JT, Vanden Hoek TL, Mehendale S, Aung H, Li CQ, et al. Antioxidant effects of American ginseng berry extract in cardiomyocytes exposed to acute oxidant stress. Biochim Biophys Acta 2004;1670(3):165–171.

Mehendale SR, Wang CZ, Shao ZH, Li CQ, Xie JT, Aung HH, et al. Chronic pretreatment with American ginseng berry and its polyphenolic constituents attenuate oxidant stress in cardiomyocytes. Eur J Pharmacol 2006;553:209–214.

Li J, Ichikawa T, Jin Y, Hofseth LJ, Nagarkatti P, Nagarkatti M, et al. An essential role of Nrf2 in American ginsengmediated anti-oxidative actions in cardiomyocytes. J Ethnopharmacol 2010;130:222–230.

Ahn CM, Hong SJ, Choi SC, Park JH, Kim JS, Lim DS. Red ginseng extract improves coronary flow reserve and increases absolute numbers of various circulating angiogenic cells in patients with first ST-segment elevation acute myocardial infarction. Phytother Res 2011;25:239–249.

Poindexter BJ, Allison AW, Bick RJ, Dasgupta A. Ginseng: cardiotonic in adult rat cardiomyocytes, cardiotoxic in neonatal rat cardiomyocytes. Life Sci 2006;79:2337–2344.

Liao WI, Lin YY, Chu SJ, Hsu CW, Tsai SH. Bradyarrhythmia caused by ginseng in a patient with chronic kidney disease. Am J Emerg Med 2010;28:538. e5-538.e6.

Dasgupta A, Reyes MA. Effect of Brazilian, Indian, Siberian, Asian, and North American ginseng on serum digoxin measurement by immunoassays and binding of digoxinlike immunoreactive components of ginseng with Fab fragment of antidigoxin antibody (Digibind). Am J Clin Pathol 2005;124:229–236.

Chen S, Luo H, Li Y, Sun Y, Wu Q, Niu Y, et al. 454 EST analysis detects genes putatively involved in ginsenoside biosynthesis in Panax ginseng. Plant Cell Rep 2011;30:1593–1601.